Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Revenue (2024 - 2025)

Rallybio's Revenue history spans 2 years, with the latest figure at $212000.0 for Q3 2025.

  • For Q3 2025, Revenue fell 29.1% year-over-year to $212000.0; the TTM value through Sep 2025 reached $638000.0, up 6.69%, while the annual FY2024 figure was $600000.0, N/A changed from the prior year.
  • Revenue for Q3 2025 was $212000.0 at Rallybio, roughly flat from $212000.0 in the prior quarter.
  • Across five years, Revenue topped out at $299000.0 in Q2 2024 and bottomed at $2000.0 in Q4 2024.